Where do OnKure Therapeutics, Inc.'s ratios come from?

Every ratio is computed from OnKure Therapeutics, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Returns
Return on equity	-42.7%+31.7pp	-74.4%—	——	——	——
Return on assets	-39.4%+27.9pp	-67.2%+17.1pp	-84.3%-11.1pp	-73.2%-9.2pp	-64%+5.9pp
Liquidity
Current ratio	13.8×+3.5×	10.3×-1.2×	11.4×+0.3×	11.1×0.0×	11.2×+0.4×
Quick ratio	13.8×+3.5×	10.3×-1.2×	11.4×+0.3×	11.1×0.0×	11.2×+0.4×
Cash ratio	13.4×+3.4×	10×-1.3×	11.3×+0.3×	11×0.0×	11×+0.5×
Leverage
Debt-to-equity	0×0.0×	0×0.0×	0×0.0×	0×0.0×	0×0.0×
Debt-to-assets	0×0.0×	0×0.0×	0×0.0×	0×0.0×	0×0.0×
Per Share
Book value per share	$13.48+224%	$4.16-15.3%	$4.91-15.2%	$5.79-14.3%	$6.75-77.6%
Valuation
Market capitalization	$184.2M+72.6%	$123.71M+5.6%	$117.16M+7.6%	$108.91M-40.1%	$181.92M-49.6%
Enterprise value	-$7.49M-127%	$65.21M+37.3%	$47.51M+80.3%	$26.35M-69.4%	$86.21M-65.7%
Price / book	1×-0.4×	2.2×+0.4×	1.8×+0.4×	1.4×-0.6×	2×-1.5×
Free cash flow yield	-27.5%+29.8pp	-41.9%+12.5pp	-54.4%+2.0pp	-56.3%-26.4pp	-30%-15.8pp
Earnings yield	-31.8%+24.5pp	-48.1%+6.1pp	-54.2%+1.2pp	-55.4%-22.9pp	-32.5%-17.9pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do OnKure Therapeutics, Inc.'s ratios come from?: Every ratio is computed from OnKure Therapeutics, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.